177 related articles for article (PubMed ID: 18555133)
1. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.
Trivedi HL; Vanikar AV; Thakker U; Firoze A; Dave SD; Patel CN; Patel JV; Bhargava AB; Shankar V
Transplant Proc; 2008 May; 40(4):1135-9. PubMed ID: 18555133
[TBL] [Abstract][Full Text] [Related]
2. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
[TBL] [Abstract][Full Text] [Related]
3. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.
Dave SD; Vanikar AV; Trivedi HL; Thakkar UG; Gopal SC; Chandra T
Clin Exp Med; 2015 Feb; 15(1):41-5. PubMed ID: 24317657
[TBL] [Abstract][Full Text] [Related]
4. Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus.
Vanikar AV; Dave SD; Thakkar UG; Trivedi HL
Stem Cells Int; 2010 Dec; 2010():582382. PubMed ID: 21197448
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.
Dave SD; Trivedi HL; Gopal SC; Chandra T
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199184
[TBL] [Abstract][Full Text] [Related]
6. Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
Thakkar UG; Vanikar AV; Trivedi HL
Biomed J; 2013; 36(6):304-7. PubMed ID: 24385073
[TBL] [Abstract][Full Text] [Related]
7. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Couri CE; Oliveira MC; Stracieri AB; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Martinez EZ; Foss MC; Burt RK; Voltarelli JC
JAMA; 2009 Apr; 301(15):1573-9. PubMed ID: 19366777
[TBL] [Abstract][Full Text] [Related]
8. Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells.
Trivedi HL; Thakkar UG; Vanikar AV; Dave SD
BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679189
[TBL] [Abstract][Full Text] [Related]
9. Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.
Dave SD; Trivedi HL; Chooramani SG; Chandra T
BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23893283
[TBL] [Abstract][Full Text] [Related]
10. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
[TBL] [Abstract][Full Text] [Related]
11. Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.
Dave SD; Vanikar AV; Trivedi HL
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709153
[TBL] [Abstract][Full Text] [Related]
12. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
Vanikar AV; Trivedi HL; Kumar A; Gopal SC; Patel HV; Gumber MR; Kute VB; Shah PR; Dave SD
Ren Fail; 2014 Oct; 36(9):1376-84. PubMed ID: 25246338
[TBL] [Abstract][Full Text] [Related]
13. Autologous Mesenchymal Stem Cell Transplant in Patients with Type 1 Diabetes Mellitus.
Ulyanova O; Askarov M; Kozina L; Karibekov T; Shaimardanova G; Zhakupova A; Danilova D; Serebrennikova D
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):236-238. PubMed ID: 30777564
[TBL] [Abstract][Full Text] [Related]
14. Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis.
Madani S; Amanzadi M; Aghayan HR; Setudeh A; Rezaei N; Rouhifard M; Larijani B
Syst Rev; 2022 May; 11(1):82. PubMed ID: 35501872
[TBL] [Abstract][Full Text] [Related]
15. Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study.
Araujo DB; Dantas JR; Silva KR; Souto DL; Pereira MFC; Moreira JP; Luiz RR; Claudio-Da-Silva CS; Gabbay MAL; Dib SA; Couri CEB; Maiolino A; Rebelatto CLK; Daga DR; Senegaglia AC; Brofman PRS; Baptista LS; Oliveira JEP; Zajdenverg L; Rodacki M
Front Immunol; 2020; 11():993. PubMed ID: 32582156
[No Abstract] [Full Text] [Related]
16. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness.
Vanikar AV; Trivedi HL; Feroze A; Kanodia KV; Dave SD; Shah PR
Int Urol Nephrol; 2011 Mar; 43(1):225-32. PubMed ID: 20084457
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
[TBL] [Abstract][Full Text] [Related]
18. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice.
Hashemi SM; Hassan ZM; Hossein-Khannazer N; Pourfathollah AA; Soudi S
Inflammopharmacology; 2020 Apr; 28(2):585-601. PubMed ID: 31741175
[TBL] [Abstract][Full Text] [Related]
19. [The hopes of the mesenchymal stem cells in regenerative medicine].
Bourin P; Gadelorge M
Transfus Clin Biol; 2007 May; 14(1):120-6. PubMed ID: 17513155
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.
Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML
Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
